These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34278175)

  • 1. Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation.
    Itoh S; Yoshizumi T; Kitamura Y; Yugawa K; Iseda N; Shimagaki T; Nagao Y; Toshima T; Harada N; Kohashi K; Baba S; Ishigami K; Oda Y; Mori M
    Hepatol Commun; 2021 Jul; 5(7):1278-1289. PubMed ID: 34278175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma.
    Zhou X; Hu Y; Sun H; Chen R; Huang G; Liu J
    Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3107-3115. PubMed ID: 37147479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive evaluation of tumor immune microenvironment in patients with clear cell renal cell carcinoma using metabolic parameter from preoperative 2-[
    Wu C; Cui Y; Liu J; Ma L; Xiong Y; Gong Y; Zhao Y; Zhang X; Chen S; He Q; Zhang J; Liu M; Fan Y
    Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4054-4066. PubMed ID: 33978830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insight on the correlation of metabolic status on
    Wang Y; Zhao N; Wu Z; Pan N; Shen X; Liu T; Wei F; You J; Xu W; Ren X
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1127-1136. PubMed ID: 31502013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with
    Risør LM; Clausen MM; Ujmajuridze Z; Farhadi M; Andersen KF; Loft A; Friborg J; Kjaer A
    J Nucl Med; 2022 Aug; 63(8):1169-1176. PubMed ID: 34857658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation.
    Itoh S; Yoshizumi T; Yugawa K; Imai D; Yoshiya S; Takeishi K; Toshima T; Harada N; Ikegami T; Soejima Y; Kohashi K; Oda Y; Mori M
    Hepatology; 2020 Dec; 72(6):1987-1999. PubMed ID: 32112577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining PD-L1 Expression and Standardized Uptake Values in FDG-PET/CT Can Predict Prognosis in Patients With Resectable Non-Small-Cell Lung Cancer.
    Miyazawa T; Otsubo K; Sakai H; Kimura H; Chosokabe M; Morikawa K; Furuya N; Marushima H; Kojima K; Mineshita M; Koike J; Saji H
    Cancer Control; 2021; 28():10732748211038314. PubMed ID: 34384268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic values of ALDOB expression and
    Jia W; Wu Q; Yu X; Shen M; Zhang R; Li J; Zhao L; Huang G; Liu J
    Front Oncol; 2022; 12():1044902. PubMed ID: 36644641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic characteristics of programmed cell death-ligand 1-expressing lung cancer on
    Takada K; Toyokawa G; Okamoto T; Baba S; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takamori S; Katsura M; Shoji F; Honda H; Oda Y; Maehara Y
    Cancer Med; 2017 Nov; 6(11):2552-2561. PubMed ID: 28980429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between PD-L1 expression and metabolic parameters of
    Xu X; Li J; Yang Y; Sang S; Deng S
    Clin Imaging; 2022 Sep; 89():120-127. PubMed ID: 35797878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of volume-based 18F-FDG PET/CT parameters and correlation with PD-L1 expression in patients with surgically resected lung adenocarcinoma.
    Wang D; Li Y; Chen X; Li P
    Medicine (Baltimore); 2021 Sep; 100(35):e27100. PubMed ID: 34477147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of tumor-related immunity with 18F-FDG-PET in pulmonary squamous-cell carcinoma.
    Kasahara N; Kaira K; Bao P; Higuchi T; Arisaka Y; Erkhem-Ochir B; Sunaga N; Ohtaki Y; Yajima T; Kosaka T; Oyama T; Yokobori T; Asao T; Nishiyama M; Tsushima Y; Kuwano H; Shimizu K; Mogi A
    Lung Cancer; 2018 May; 119():71-77. PubMed ID: 29656756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Value of
    Vekens K; Everaert H; Neyns B; Ilsen B; Decoster L
    Clin Lung Cancer; 2021 Sep; 22(5):432-440. PubMed ID: 33879398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.
    Lin CY; Liao CW; Chu LY; Yen KY; Jeng LB; Hsu CN; Lin CL; Kao CH
    Clin Nucl Med; 2017 Apr; 42(4):e183-e187. PubMed ID: 28114226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 in Lung Adenocarcinoma: Insights into the Role of
    Cui Y; Li X; Du B; Diao Y; Li Y
    Cancer Manag Res; 2020; 12():6385-6395. PubMed ID: 32801879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the expression of PD-1/PD-L1 and
    Chen R; Zhou X; Liu J; Huang G
    Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):848-854. PubMed ID: 30627815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Standardized Uptake Value of Metastatic Lymph Nodes Measured by 18F-FDG PET/CT Improves the Prediction of Prognosis in Gastric Cancer.
    Song BI; Kim HW; Won KS; Ryu SW; Sohn SS; Kang YN
    Medicine (Baltimore); 2015 Jul; 94(26):e1037. PubMed ID: 26131811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of PD-L1 expression and
    Zhang M; Wang D; Sun Q; Pu H; Wang Y; Zhao S; Wang Y; Zhang Q
    Oncotarget; 2017 Aug; 8(31):51630-51640. PubMed ID: 28881674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of amide proton transfer-weighted imaging for assessing programmed death-ligand 1 status in non-small cell lung cancer: a comparative study with intravoxel incoherent motion and
    Meng N; Fu F; Sun J; Feng P; Luo Y; Wu Y; Li X; Yuan J; Yang Y; Liu H; Wang Z; Wang M
    Quant Imaging Med Surg; 2022 Sep; 12(9):4474-4487. PubMed ID: 36060584
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Jreige M; Mitsakis P; Van Der Gucht A; Pomoni A; Silva-Monteiro M; Gnesin S; Boubaker A; Nicod-Lalonde M; Duran R; Prior JO; Denys A; Schaefer N
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1215-1222. PubMed ID: 28233086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.